However, in diseases like inflammatory bowel disease (IBD), dysbiosis leads to elevated lipopolysaccharide (LPS) levels and increased cytokine production, disrupting the expression of key vitamin D hydroxylases, including CYP27B1 and CYP24A1. The gene discussed is CYP24A1; the disease is inflammatory bowel disease.